Skip to main content
. 2022 Nov 23;2022(11):CD010612. doi: 10.1002/14651858.CD010612.pub3

Comparison 1. Early versus standard initiation.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Death 12   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.1.1 Death at day 30 12 4826 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.87, 1.09]
1.1.2 Death after 30 days 7 4534 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.92, 1.07]
1.2 Death or non‐recovery kidney function at day 90 6 4011 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.74, 1.11]
1.3 Recovery of kidney function 10   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.3.1 Patients free from KRT according to ITT analysis (all patients) 10 4717 Risk Ratio (M‐H, Random, 95% CI) 1.07 [0.94, 1.22]
1.3.2 Survivors free from KRT according to ITT after 30 days 10 2510 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.97, 1.07]
1.4 Adverse events 7   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.4.1 Any adverse event 5 3983 Risk Ratio (M‐H, Random, 95% CI) 1.23 [0.90, 1.68]
1.4.2 Hypophosphataemia 1 2927 Risk Ratio (M‐H, Random, 95% CI) 1.80 [1.33, 2.44]
1.4.3 Hypotension 5 3864 Risk Ratio (M‐H, Random, 95% CI) 1.54 [1.29, 1.85]
1.4.4 Cardiac‐rhythm disorder 6 4483 Risk Ratio (M‐H, Random, 95% CI) 1.35 [1.04, 1.75]
1.4.5 Infection 5 4252 Risk Ratio (M‐H, Random, 95% CI) 1.33 [1.00, 1.77]
1.4.6 Bleeding 6 4358 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.71, 1.18]
1.4.7 Thrombocytopenia 1 106 Risk Ratio (M‐H, Random, 95% CI) 1.03 [0.20, 5.35]
1.5 Length of stay 7   Mean Difference (IV, Random, 95% CI) Subtotals only
1.5.1 Length of stay in ICU 5 4240 Mean Difference (IV, Random, 95% CI) ‐1.01 [‐1.60, ‐0.42]
1.5.2 Length of stay in hospital 7 4589 Mean Difference (IV, Random, 95% CI) ‐2.45 [‐4.75, ‐0.14]